Dr. Parul Maheshwari Sharma

Dr. Parul Maheshwari Sharma is a distinguished ophthalmologist with over 25 years of experience, specializing in Glaucoma, Cataract surgery, Refractive surgery, Squint, Keratoconus, and Pediatric eye care. As the Principal Director & HOD of Ophthalmology at Fortis Memorial Research Institute, Gurugram, she is recognized as one of the best eye specialists in India. Dr. Sharma has trained at prestigious institutions, including Moorfield Eye Hospital in London, LV Prasad Eye Institute in Hyderabad, and Singapore National Eye Centre, equipping her with advanced skills in ophthalmic surgery and patient care.

She has performed over 100,000 eye surgeries and treated more than 400,000 patients, showcasing her expertise and dedication to vision care. Her patient-centric approach, ethical practice, and use of cutting-edge technology make her a trusted choice for international patients seeking advanced eye treatment in India. Dr. Sharma’s commitment to precision and patient satisfaction has earned her widespread acclaim, as evidenced by positive testimonials on her website (https://www.drparulsharma.com/).

Dr. Sharma specializes in diagnosing and managing a wide range of eye conditions, including:

• Glaucoma
• Cataract
• Refractive Errors (Myopia, Hypermetropia, Astigmatism)
• Squint
• Keratoconus
• Pediatric Eye Disorders

• Cataract Surgery (FEMTO BLADELESS & Micro Phacoemulsification)
• Refractive Surgery (FEMTO BLADELESS Lasik, PRK, Phakic ICL)
• Glaucoma Surgery
• Squint Correction Surgery
• Keratoconus Management
• Pediatric Eye Surgeries

Dr. Sharma completed her MBBS and MS in Ophthalmology from JNMC, Aligarh Muslim University, followed by DNB, MNAMS, and FICO (UK). Her training at globally renowned institutions like Moorfield Eye Hospital, LV Prasad Eye Institute, and Singapore National Eye Centre has honed her expertise in advanced ophthalmic techniques. She has contributed to medical education through publications and presentations at national and international conferences.

Dr. Sharma also operates at Viaan Eye Centre, Sector 57, Gurugram, further extending her reach in providing quality eye care. Her leadership as Principal Director & HOD at Fortis underscores her influence in the field.

Dr. Parul Maheshwari Sharma’s expertise, global training, and compassionate care make her an ideal choice for those seeking world-class eye treatment in India.

Proven Clinical Excellence: Over 25 years of experience with more than 100,000 successful eye surgeries, including complex cases. High patient satisfaction rates, with testimonials praising her precision and care (https://www.drparulsharma.com/patient-feedback-cataract). Ethical practice ensures only necessary treatments are recommended, prioritizing patient welfare.

Global Training and Exposure: Trained at world-class institutions like Moorfield Eye Hospital (London), LV Prasad Eye Institute (Hyderabad), and Singapore National Eye Centre. Holds international qualifications (FICO, UK), ensuring adherence to global standards in eye care.

Personalized and Holistic Approach: Tailors treatment plans to individual needs, focusing on preventive care and long-term vision health. Known for empathetic communication, as noted in patient reviews, fostering trust and comfort.

Advanced Technology and Techniques: Utilizes cutting-edge technology like FEMTO BLADELESS Lasik and Micro Phacoemulsification for superior outcomes. Expertise in minimally invasive procedures reduces recovery time and enhances patient comfort.

Patient-Centric International Care: Fortis Memorial Research Institute offers translators, prayer rooms, money exchange, and an international patient lounge for medical tourists (https://www.fortishealthcare.com/international-patients). Seamless coordination for travel, accommodation, and post-treatment care ensures a stress-free experience.

Ethical and Transparent Practice: Transparent communication about procedures, risks, and outcomes empowers patients to make informed decisions. Commitment to ethical care builds trust, making her a preferred choice for global patients.